Timber Pharmaceuticals, Inc.
TMBR · AMEX
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $1 |
| - Cash | $3 | $5 | $9 | $11 |
| + Debt | $1 | $1 | $0 | $0 |
| Enterprise Value | -$1 | -$4 | -$8 | -$10 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$2 | -$2 | -$2 | -$2 |
| % Margin | – | – | -2,425.9% | – |
| EBITDA | -$4 | -$4 | -$3 | -$3 |
| % Margin | – | – | -4,166.6% | – |
| Net Income | -$4 | -$4 | -$4 | -$3 |
| % Margin | – | – | -4,355.5% | – |
| EPS Diluted | -1.32 | -1.36 | -1.72 | -1.52 |
| % Growth | 2.9% | 20.9% | -13.2% | – |
| Operating Cash Flow | -$3 | -$4 | -$3 | -$4 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$3 | -$4 | -$3 | -$4 |